GLP-1 inhibitors, like tirzepatide, show promise in reducing AHI in OSA patients with obesity, as demonstrated in the SURMOUNT trials. Experts highlight the importance of integrating GLP-1s with diet ...
Sleep apnea? What’s that? It may be a new medical term and condition for you; you may not even know you are experiencing it.
Progressive discontinuation of antihypertensive medications did not lower risk for mortality compared with usual care among ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results